IVI RMA North America Partners with University of Utah to Expand Fertility Services
Event summary
- IVI RMA North America has entered a strategic affiliation with University of Utah Health to expand fertility care access in the Mountain West region.
- The collaboration will focus on training reproductive endocrinologists (REIs) and advancing reproductive medicine research.
- A new, state-of-the-art fertility laboratory is planned for 2028, jointly supported by both organizations.
- University of Utah Health has a $531 million research enterprise and trains over 1,478 healthcare providers annually.
- IVI RMA North America has facilitated over 220,000 births and published over 1,000 research papers.
The big picture
The partnership reflects a growing trend of specialized fertility clinics seeking to integrate with larger academic health systems to expand geographic reach, enhance research capabilities, and address the persistent shortage of reproductive endocrinologists. IVI RMA North America, a significant player in the global assisted reproduction market, is strategically positioning itself to capitalize on this trend and solidify its presence in the US market. This move also highlights the increasing importance of specialized training programs to meet the demand for advanced reproductive care.
What we're watching
- Market Penetration
- How effectively IVI RMA North America can leverage University of Utah Health’s regional reach to expand access to fertility services in underserved communities remains to be seen, particularly given the logistical challenges of rural care.
- Talent Pipeline
- Whether the joint REI training program can consistently produce a sufficient number of qualified specialists to meet growing demand and address the existing physician shortage in reproductive endocrinology will be a key indicator of long-term success.
- Lab Operations
- The success of the planned 2028 fertility laboratory will depend on seamless integration of IVI RMA’s operational expertise with University of Utah’s existing infrastructure and research capabilities.
